Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.

Sun X, Pulit-Penaloza JA, Belser JA, Pappas C, Pearce MB, Brock N, Zeng H, Creager HM, Zanders N, Jang Y, Tumpey TM, Davis CT, Maines TR.

J Virol. 2018 Jul 31;92(16). pii: e00665-18. doi: 10.1128/JVI.00665-18. Print 2018 Aug 15.

2.

Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.

Belser JA, Johnson A, Pulit-Penaloza JA, Pappas C, Pearce MB, Tzeng WP, Hossain MJ, Ridenour C, Wang L, Chen LM, Wentworth DE, Katz JM, Maines TR, Tumpey TM.

Virology. 2017 Nov;511:135-141. doi: 10.1016/j.virol.2017.08.024. Epub 2017 Aug 29.

3.

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM.

Virology. 2017 Sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. Epub 2017 Jun 16.

4.

Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.

Van Epps P, Tumpey T, Pearce MB, Golding H, Higgins P, Hornick T, Burant C, Wilson BM, Banks R, Gravenstein S, Canaday DH.

Clin Vaccine Immunol. 2017 Mar 6;24(3). pii: e00498-16. doi: 10.1128/CVI.00498-16. Print 2017 Mar.

5.

Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets.

Pearce MB, Pappas C, Gustin KM, Davis CT, Pantin-Jackwood MJ, Swayne DE, Maines TR, Belser JA, Tumpey TM.

Virology. 2017 Feb;502:114-122. doi: 10.1016/j.virol.2016.12.024. Epub 2016 Dec 27.

6.

Phase 1 study of pandemic H1 DNA vaccine in healthy adults.

Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z, Enama ME, Holman LA, Bailer RT, Pearce MB, Koup RA, Mascola JR, Nabel GJ, Tumpey TM, Schwartz RM, Graham BS, Ledgerwood JE; VRC 308 Study Team.

PLoS One. 2015 Apr 17;10(4):e0123969. doi: 10.1371/journal.pone.0123969. eCollection 2015.

7.

Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.

Liu YV, Massare MJ, Pearce MB, Sun X, Belser JA, Maines TR, Creager HM, Glenn GM, Pushko P, Smith GE, Tumpey TM.

Vaccine. 2015 Apr 27;33(18):2152-8. doi: 10.1016/j.vaccine.2015.03.009. Epub 2015 Mar 13.

8.

Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets.

Pappas C, Yang H, Carney PJ, Pearce MB, Katz JM, Stevens J, Tumpey TM.

Virology. 2015 Mar;477:61-71. doi: 10.1016/j.virol.2015.01.002. Epub 2015 Feb 5.

9.

Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.

Houser KV, Pearce MB, Katz JM, Tumpey TM.

J Virol. 2013 Dec;87(24):13480-9. doi: 10.1128/JVI.02434-13. Epub 2013 Oct 2.

10.

Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice.

Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J, Katz JM, Tumpey TM.

Nature. 2013 Sep 26;501(7468):556-9. doi: 10.1038/nature12391. Epub 2013 Jul 10.

PMID:
23842497
11.

Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus.

Zhou B, Pearce MB, Li Y, Wang J, Mason RJ, Tumpey TM, Wentworth DE.

PLoS One. 2013 Jun 14;8(6):e67616. doi: 10.1371/journal.pone.0067616. Print 2013.

12.

Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses.

Tretyakova I, Pearce MB, Florese R, Tumpey TM, Pushko P.

Virology. 2013 Jul 20;442(1):67-73. doi: 10.1016/j.virol.2013.03.027. Epub 2013 Apr 22.

13.

Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.

Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS; VRC 304 and VRC 305 Study Teams.

Clin Vaccine Immunol. 2012 Nov;19(11):1792-7. doi: 10.1128/CVI.05663-11. Epub 2012 Sep 5.

14.

Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.

Pearce MB, Belser JA, Gustin KM, Pappas C, Houser KV, Sun X, Maines TR, Pantin-Jackwood MJ, Katz JM, Tumpey TM.

J Virol. 2012 Jul;86(13):7118-25. doi: 10.1128/JVI.00674-12. Epub 2012 May 2.

15.

Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets.

Pearce MB, Jayaraman A, Pappas C, Belser JA, Zeng H, Gustin KM, Maines TR, Sun X, Raman R, Cox NJ, Sasisekharan R, Katz JM, Tumpey TM.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3944-9. doi: 10.1073/pnas.1119945109. Epub 2012 Feb 21.

16.

Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.

Belser JA, Sleeman K, Pearce MB, Katz JM, Gubareva LV, Tumpey TM.

Antimicrob Agents Chemother. 2012 Mar;56(3):1616-8. doi: 10.1128/AAC.06101-11. Epub 2011 Dec 12.

17.

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.

Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS; VRC 306 Study Team.

Lancet Infect Dis. 2011 Dec;11(12):916-24. doi: 10.1016/S1473-3099(11)70240-7. Epub 2011 Oct 3.

PMID:
21975270
18.

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.

Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.

Vaccine. 2011 Aug 11;29(35):5911-8. doi: 10.1016/j.vaccine.2011.06.068. Epub 2011 Jun 30.

PMID:
21723354
19.

Influenza virus aerosol exposure and analytical system for ferrets.

Gustin KM, Belser JA, Wadford DA, Pearce MB, Katz JM, Tumpey TM, Maines TR.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8432-7. doi: 10.1073/pnas.1100768108. Epub 2011 May 2.

20.

Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.

Maines TR, Chen LM, Van Hoeven N, Tumpey TM, Blixt O, Belser JA, Gustin KM, Pearce MB, Pappas C, Stevens J, Cox NJ, Paulson JC, Raman R, Sasisekharan R, Katz JM, Donis RO.

Virology. 2011 Apr 25;413(1):139-47. doi: 10.1016/j.virol.2011.02.015. Epub 2011 Mar 23.

21.

Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.

Pearce MB, Belser JA, Houser KV, Katz JM, Tumpey TM.

Vaccine. 2011 Apr 5;29(16):2887-94. doi: 10.1016/j.vaccine.2011.02.014. Epub 2011 Feb 21.

PMID:
21338676
22.

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Price GE, Soboleski MR, Lo CY, Misplon JA, Quirion MR, Houser KV, Pearce MB, Pappas C, Tumpey TM, Epstein SL.

PLoS One. 2010 Oct 4;5(10):e13162. doi: 10.1371/journal.pone.0013162.

23.

NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets.

Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, García-Sastre A, Tumpey TM, Wentworth DE.

Vaccine. 2010 Nov 23;28(50):8015-25. doi: 10.1016/j.vaccine.2010.08.106. Epub 2010 Oct 8.

24.

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.

Science. 2010 Aug 27;329(5995):1060-4. doi: 10.1126/science.1192517. Epub 2010 Jul 15.

25.

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.

Ranjan P, Jayashankar L, Deyde V, Zeng H, Davis WG, Pearce MB, Bowzard JB, Hoelscher MA, Jeisy-Scott V, Wiens ME, Gangappa S, Gubareva L, García-Sastre A, Katz JM, Tumpey TM, Fujita T, Sambhara S.

Virol J. 2010 May 21;7:102. doi: 10.1186/1743-422X-7-102.

26.

Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.

Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM.

Vaccine. 2010 Jul 5;28(30):4771-6. doi: 10.1016/j.vaccine.2010.04.093. Epub 2010 May 12.

PMID:
20470801
27.

Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.

Wei CJ, Boyington JC, Dai K, Houser KV, Pearce MB, Kong WP, Yang ZY, Tumpey TM, Nabel GJ.

Sci Transl Med. 2010 Mar 24;2(24):24ra21. doi: 10.1126/scitranslmed.3000799.

28.

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM.

J Virol. 2010 May;84(9):4194-203. doi: 10.1128/JVI.02742-09. Epub 2010 Feb 24.

29.

PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models.

Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, Pearce MB, García-Sastre A, Tumpey TM, Palese P.

J Virol. 2010 May;84(9):4442-50. doi: 10.1128/JVI.02717-09. Epub 2010 Feb 24.

30.

Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.

Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE Jr.

J Virol. 2010 Mar;84(6):3127-30. doi: 10.1128/JVI.02184-09. Epub 2009 Dec 30.

31.

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

Triana-Baltzer GB, Gubareva LV, Nicholls JM, Pearce MB, Mishin VP, Belser JA, Chen LM, Chan RW, Chan MC, Hedlund M, Larson JL, Moss RB, Katz JM, Tumpey TM, Fang F.

PLoS One. 2009 Nov 6;4(11):e7788. doi: 10.1371/journal.pone.0007788.

32.

RIG-I activation inhibits ebolavirus replication.

Spiropoulou CF, Ranjan P, Pearce MB, Sealy TK, Albariño CG, Gangappa S, Fujita T, Rollin PE, Nichol ST, Ksiazek TG, Sambhara S.

Virology. 2009 Sep 15;392(1):11-5. doi: 10.1016/j.virol.2009.06.032. Epub 2009 Jul 23.

33.

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH, Raman R, Cox NJ, Sasisekharan R, Katz JM, Tumpey TM.

Science. 2009 Jul 24;325(5939):484-7. doi: 10.1126/science.1177238. Epub 2009 Jul 2.

34.

Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.

Buchwald H, Varco RL, Boen JR, Williams SE, Hansen BJ, Campos CT, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr, Sawin HS Jr.

Arch Intern Med. 1998 Jun 8;158(11):1253-61.

PMID:
9625405
35.

Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction.

Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce MB, Yellin AE, Smink RD Jr, Sawin HS Jr, et al.

J Clin Epidemiol. 1995 Mar;48(3):389-405.

PMID:
7897460
36.

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group.

Buchwald H, Matts JP, Fitch LL, Campos CT, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Pearce MB, Bissett JK, et al.

JAMA. 1992 Sep 16;268(11):1429-33.

PMID:
1512911
37.

Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group.

Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr, et al.

Control Clin Trials. 1991 Apr;12(2):314-39.

PMID:
1645643
38.

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr, et al.

N Engl J Med. 1990 Oct 4;323(14):946-55.

39.

The Program on the Surgical Control of the Hyperlipidemias: a status report.

Buchwald H, Moore RB, Matts JP, Long JM, Varco RL, Campbell GS, Pearce MB, Yellin AE, Blankenhorn DH, Holmes WL, Smink RD Jr, Sawin HS Jr.

Surgery. 1982 Oct;92(4):654-62.

PMID:
6750834
40.

Management of thoracic outlet syndrome.

McGough EC, Pearce MB, Byrne JP.

J Thorac Cardiovasc Surg. 1979 Feb;77(2):169-74.

PMID:
762957
41.

Metabolic acidosis from the loss of thoracic lymph.

Siegler RL, Pearce MB.

J Pediatr. 1978 Sep;93(3):465-6. No abstract available.

PMID:
690766
42.

Electrocardiogram of the month.

Pearce MB.

J Ark Med Soc. 1976 Apr;72(11):464. No abstract available.

PMID:
130371
43.

Surgery for coronary artery disease: an appraisal.

Williams GD, Bulloch RT, Pearce MB.

J Ark Med Soc. 1975 Dec;72(7):290-3. No abstract available.

PMID:
127783
44.

Electric control of the heart. Pacemakers, cardioversion and defibrillation. I.

Williams GD, Bulloch RT, Pearce MB, Ratts TE, Kizziar JC.

Curr Probl Surg. 1974 Feb:1-67. Review. No abstract available.

PMID:
4593333
45.

The correlation of metabolic and ultrastructural changes in emetine myocardial toxicity.

Murphy ML, Bulloch RT, Pearce MB.

Am Heart J. 1974 Jan;87(1):105-8. No abstract available.

PMID:
4808746
46.

Myocardial lesions in idiopathic and alcoholic cardiomyopathy. Study by ventricular septal biopsy.

Bulloch RT, Pearce MB, Murphy ML, Jenkins BJ, Davis JL.

Am J Cardiol. 1972 Jan;29(1):15-25. No abstract available.

PMID:
5061696
47.

Selective damage of myocardial mitochondria due to emetine hydrochloride.

Pearce MB, Bulloch RT, Murphy ML.

Arch Pathol. 1971 Jan;91(1):8-18. No abstract available.

PMID:
5538625
48.

Fine structural lesions in the myocardium of a beer drinker with reversible heart failure.

Bulloch RT, Murphy ML, Pearce MB.

Am Heart J. 1970 Nov;80(5):629-37. No abstract available.

PMID:
5474100
49.

Surgical management of metastatic cancer in the lung.

Pearce MB, Vaughn CC.

Ariz Med. 1970 Jan;27(1):65-7. No abstract available.

PMID:
5412498
50.

Management of acute arterial injuries: experience with one hundred consecutive patients.

Pearce MB Jr, Drez DJ, Gibson WE 3rd, Pearce CW.

South Med J. 1969 Dec;62(12):1509-13. No abstract available.

PMID:
5372067

Supplemental Content

Loading ...
Support Center